New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3

Authors

Nace Zidar 1, Tihomir Tomašič 2, Danijel Kikelj 2, Martina Durcik 2, Jan Tytgat 3, Steve Peigneur 3, Marc Rogers 4, Alexander Haworth 4, Robert W Kirby 4

Affiliations

1University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000, Ljubljana, Slovenia. Electronic address: nace.zidar@ffa.uni-lj.si.

2University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000, Ljubljana, Slovenia.

3University of Leuven (KU Leuven), Toxicology & Pharmacology, O&N2, PO Box 922, Herestraat 49, 3000, Leuven, Belgium.

4Metrion Biosciences Limited, Building 2, Granta Centre, Granta Park, Great Abington, Cambridge, CB21 6AL, UK.

Journal

European Journal of Medicinal Chemistry, 2023

PubMed

New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3


ViewView
Recommended Publications
Latest Publications
Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806

NS5806, widely used as a Kv4-selective activator, also activates TREK-1 and TREK-2 potassium channels.

The nucleobase guanine at the 3'-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity

Nature Communications paper ‘The nucleobase guanine at the 3′-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity'

View All
Meet our scientific leadership team pain experts
Evaluation of hNav1.9 Screening Cascade for Analgesic Drug Discovery
View All
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram